Advertisement
Screener

EVOKE PHARMA, INC. Net Cash Provided by (Used in) Financing Activities, Continuing Operations

EVOKE PHARMA, INC. Net Cash Provided by (Used in) Financing Activities, Continuing Operations

EVOKE PHARMA, INC. reported Net Cash Provided by (Used in) Financing Activities, Continuing Operations of $544.64 thousand for the 3-month period ending 2018-03-31, per its 10-Q filed 2018-05-14.

Discontinued › Cash Flow › Financing Activities

us-gaap:NetCashProvidedByUsedInFinancingActivitiesContinuingOperations · last filed 2018-05-14

  • EVOKE PHARMA, INC. net cash provided by (used in) financing activities, continuing operations for the quarter ending 2018-03-31 was $544.64K, a 92.57% decline year-over-year.
  • EVOKE PHARMA, INC. net cash provided by (used in) financing activities, continuing operations for the quarter ending 2017-12-31 was $0.00.
  • EVOKE PHARMA, INC. net cash provided by (used in) financing activities, continuing operations for the quarter ending 2017-09-30 was $56.86K, a 99.34% decline year-over-year.
  • EVOKE PHARMA, INC. net cash provided by (used in) financing activities, continuing operations for the quarter ending 2017-06-30 was -$2.50K, a 100.96% decline year-over-year.
  • EVOKE PHARMA, INC. net cash provided by (used in) financing activities, continuing operations for fiscal 2017 was $7.39M, a 18.11% decline from fiscal 2016.
  • EVOKE PHARMA, INC. net cash provided by (used in) financing activities, continuing operations for fiscal 2016 was $9.02M, a 79.35% increase from fiscal 2015.
  • EVOKE PHARMA, INC. net cash provided by (used in) financing activities, continuing operations for fiscal 2015 was $5.03M, a 244.56% increase from fiscal 2014.
  • EVOKE PHARMA, INC. net cash provided by (used in) financing activities, continuing operations for fiscal 2014 was $1.46M, a 94.62% decline from fiscal 2013.
Period endNet Cash Provided by (Used in) Financing Activities, Continuing Operations 3 monthNet Cash Provided by (Used in) Financing Activities, Continuing Operations 6 monthNet Cash Provided by (Used in) Financing Activities, Continuing Operations 9 monthNet Cash Provided by (Used in) Financing Activities, Continuing Operations 12 month
2018-03-31$544.64K
10-Q · filed 2018-05-14
$544.64K
derived: sum of 2 quarters · filed 2018-05-14
$601.50K
derived: sum of 3 quarters · filed 2018-05-14
$599.00K
derived: sum of 4 quarters · filed 2018-05-14
2017-12-31$0.00
derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-07
$56.86K
derived: sum of 2 quarters · filed 2018-03-07
$54.36K
derived: sum of 3 quarters · filed 2018-03-07
$7.39M
10-K · filed 2018-03-07
2017-09-30$56.86K
derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-14
$54.36K
derived: sum of 2 quarters · filed 2017-11-14
$7.39M
10-Q · filed 2017-11-14
$7.39M
derived: sum of 4 quarters · filed 2018-05-14
2017-06-30-$2.50K
derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-14
$7.33M
10-Q · filed 2017-08-14
$7.33M
derived: sum of 3 quarters · filed 2018-05-14
$16.00M
derived: sum of 4 quarters · filed 2018-05-14
2017-03-31$7.33M
10-Q · filed 2018-05-14
$7.33M
derived: sum of 2 quarters · filed 2018-05-14
$16.00M
derived: sum of 3 quarters · filed 2018-05-14
$16.26M
derived: sum of 4 quarters · filed 2018-05-14
2016-12-31-$3.17K
derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-07
$8.67M
derived: sum of 2 quarters · filed 2018-03-07
$8.92M
derived: sum of 3 quarters · filed 2018-03-07
$9.02M
10-K · filed 2018-03-07
2016-09-30$8.67M
derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-14
$8.93M
derived: sum of 2 quarters · filed 2017-11-14
$9.03M
10-Q · filed 2017-11-14
$9.43M
derived: sum of 4 quarters · filed 2017-11-14
2016-06-30$259.28K
derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-14
$358.02K
10-Q · filed 2017-08-14
$762.83K
derived: sum of 3 quarters · filed 2017-08-14
$4.12M
derived: sum of 4 quarters · filed 2017-08-14
2016-03-31$98.74K
10-Q · filed 2017-05-15
$503.56K
derived: sum of 2 quarters · filed 2017-05-15
$3.86M
derived: sum of 3 quarters · filed 2017-05-15
$4.60M
derived: sum of 4 quarters · filed 2017-05-15
2015-12-31$404.81K
derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-15
$3.76M
derived: sum of 2 quarters · filed 2017-03-15
$4.50M
derived: sum of 3 quarters · filed 2017-03-15
$5.03M
10-K · filed 2017-03-15
2015-09-30$3.36M
derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-09
$4.09M
derived: sum of 2 quarters · filed 2016-11-09
$4.63M
10-Q · filed 2016-11-09
$9.13M
derived: sum of 4 quarters · filed 2016-11-09
2015-06-30$734.91K
derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-15
$1.27M
10-Q · filed 2016-08-15
$5.77M
derived: sum of 3 quarters · filed 2016-08-15
$5.81M
derived: sum of 4 quarters · filed 2016-08-15
2015-03-31$531.62K
10-Q · filed 2016-05-11
$5.03M
derived: sum of 2 quarters · filed 2016-05-11
$5.07M
derived: sum of 3 quarters · filed 2016-05-11
$2.35M
derived: sum of 4 quarters · filed 2016-05-11
2014-12-31$4.50M
derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-10
$4.54M
derived: sum of 2 quarters · filed 2016-03-10
$1.82M
derived: sum of 3 quarters · filed 2016-03-10
$1.46M
10-K · filed 2016-03-10
2014-09-30$42.88K
derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-12
-$2.68M
derived: sum of 2 quarters · filed 2015-11-12
-$3.04M
10-Q · filed 2015-11-12
-$691.90K
derived: sum of 4 quarters · filed 2015-11-12
2014-06-30-$2.72M
derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-13
-$3.08M
10-Q · filed 2015-08-13
-$734.78K
derived: sum of 3 quarters · filed 2015-08-13
$22.23M
derived: sum of 4 quarters · filed 2015-08-13
2014-03-31-$360.58K
10-Q · filed 2015-05-14
$1.99M
derived: sum of 2 quarters · filed 2015-05-14
$24.95M
derived: sum of 3 quarters · filed 2015-05-14
2013-12-31$2.35M
derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-04
$25.31M
derived: sum of 2 quarters · filed 2015-03-04
$27.12M
10-K · filed 2015-03-04
2013-09-30$22.96M
derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-13
$24.77M
10-Q · filed 2014-11-13
2013-06-30$1.81M
10-Q · filed 2014-08-13